Treatment or prevention agent for meibomian gland dysfunction or meibomian gland infarction

摘要

A novel pharmaceutical use of clarithromycin is provided. The present invention is a therapeutic or prophylactic agent for meibomian gland dysfunction or meibomian gland infarction containing clarithromycin as an active ingredient. The dosage form is preferably eye drops or eye ointment. [Selection figure] None